To determine
It is well established that the neuroregulation of GH secretion is under the control of two hypothalamic peptides, viz, an inhibitory tetradecapeptide, somatostatin and a stimulatory, GH-releasing factor (GRF) of which an active principal component was recently extracted from a human pancreatic islet tumor (Guillemin et al., 1982; Rivier et al., 1982) . Somatostatin containing neurons are localized in the preoptic and anterior periventricular nucleus (Finley et al., 1981) which plays an inhibitory role on pulsatile rGH secretion (Willoughby and Martin, 1978) .
On the other hand, the localization of GRF neurons has not yet been seen in the rat but the neuronal perikarya are thought to reside in the ventromedial nucleus (VMN) and the arcuate nucleus (ARN) in the light of findings in experiments involving the administration of monosodium glutamate to neonatal rats (Millard et al., 1982) and on obesity-inducing VMH lesions (Eikelboom and Tannenbaum, 1983) . However, the interrelation between the neuropharmacological findings, and localization of neuronal mechanisms which are responsible for rGH secretion remains to be disclosed. Thus, in the present experiment, we aimed to define a specific area (s) responsive to clonidine for rGH release with a microinjection technique which might give a further clue leading to unified understanding of the regulatory mechanism of GH release from both approaches. All surgical procedures were performed under pentobarbital anesthesia (50mg/kg body weight). A week prior to the acute experiments, double-walled stainless-steel cannulae (OD: 0.65mm, ID: 0.30mm) for microinjection were stereotaxically implanted unilaterally into the hypothalamic and surrounding areas from the preoptic area (PO) to the mammillary nucleus (MN), including the amygdala nucleus (AMN). With the skull leveled between the bregma (0mm) and the lambda (-1.0mm), the stereotaxic coordinates for each area posterior to the bregma, lateral to the midline and below the dura were as follows; the AMN (posterior, 2.0mm; lateral, 4.2 mm; depth, 9.0mm), the preoptic and anterior hypothalamic area (PO/AH) (posterior, -0.5mm; lateral, 0.5mm; depth, 8.0mm), the paraventicular nucleus (PVN) (posterior, 1.3mm; lateral, 0.5mm; depth, 8.3mm), the dorsomedial nucleus (DMN) (posterior, 2.0mm; lateral, 0.5mm; depth, 8.7mm), the VMH (posterior, 1.7mm; lateral, 0.6mm; depth, 9.5mm), the lateral hypothalamus (LH) (posterior, 1.8mm; lateral, 1.8mm; depth, 8.5mm), the posterior hypothalamus (PH) (posterior,3.2mm; lateral, 0.6mm; depth, 9.0mm) and the mammillary nucleus (MN) (posterior, 3.7mm; lateral, 0.6mm; depth, 9.3 mm), respectively. The double-walled cannulae were secured to the skull with small screws and dental cement. On the same occasion, chronic indwelling silastic tubes were inserted from the right jugular veins to the right atria for blood collections as previously reported (Takeuchi et al., 1978 ng/ml plasma.
The intra-and inter-assay coefficients of variation were 4 and 9% respectively. Statistical analyses were accomplished using Student's t test and analysis of variance.
Histological Examination
After the experiment, the animals were killed by decapitation, and the brains were removed and fixed in 10% formaline for 2 weeks. 40 tem thick frozen sections were made and stained with cresyl violet to identify the location of the microinjection sites. Fig.  1 shows the location of the sites. Tissue damage and haemorrhage are noticed in an area between the medial and basolateral AMN (A), and the AH (B). As shown in the figure, the visible spheres made by microinjection were less than 1 mm in diameter, although the drug diffusion might have exceeded the boundaries. PO/AH area responded to the drug microinjection to increase rGH release as shown in Fig. 2 .
In Table 1 , the results are summarized, indicating that there were no significant effect of clonidine when administered to hypothalamic areas other than the PO/AH. The clonidine insensitive areas were the PVN, the DMN, the LH and the PH/MN. When the maximal response was more than twice as much as the 0 time level in each case, we defined it as a positive response. Fig. 3 is a schematic presentation of the positive and negative sites to the clonidine microinjection, which were confirmed by histological examination.
Closed circles (positive sites) and open triangles (negative sites) were plotted on coronal and sagittal figures of Konig and Klippel's atlas (1963) . As shown in Fig. 3, a sagittal figure, there are two distinct positive regions, viz., the PO/AH and posterior areas. However, in the posterior region which contained the posterior hypothalamic, premammillary and mammillary nuclei (PH/MN), the positive response which were 6 cases out of 15 that were examined were statistically insignificant ( These areas are superimposed on drawings respresenting coronal and sagittal sections from Konig and Klippel's Atlas (1963) the ivt dose. A significant stimulatory effect of the microinjection was observed when administered to the PO/AH area, although the increase was not so marked as in seen in iv and ivt administrations (Fig. 2 and Table 1 ).
There is evidence that somatostatin containing neurons reside in the periventricular nucleus distributed in the PO/AH of the hypothalamus (Finley et al., 1981) and lesions which placed in the area followed by the decrease in somatostatin content in the median eminence increased the frequency of spontaneous rGH surge and the zenith levels (Willoughby and Martin, 1978) . In addition, stress-induced suppression of rGH release was abolished in the PO/AH-lesioned rats (Rice and Critchlow, 1976) . These findings strongly indicate the inhibitory role of somatostatinergic neurons in the preoptic and anterior periventricular nucleus in rGH release. Thus it is likely that clonidine microinjection into the area exerts an inhibitory effect on periventricular somatostatinergic neurons through an unknown mechanism(s).
The PVN, the DMN, the VMH and the LH did not respond to the drug microinjection.
At present, the localization of GRF neuronal perikarya has not yet been demonstrated in the rat but the VMH and/ the ARN are implied to be the candidate area(s). Electrical stimulation of the VMH nucleus elicits rGH release (Frohman et al., 1968 ; Bernardis and Frohman, 1971 ; Martin, 1972 ; Martin et al., 1973) . Conversely, VMH-lesioned rats showed lowered plasma GH levels (Frohman and Bernardis, 1968 ; Martin et al., 1974) in addition to the findings of retarded growth of the lesioned rats (Reichlin, 1960 ; Frohman and Bernardis, 1968) . Furthermore the administration of monosodium glutamate to neonatal rats results in a selective destruction of neuronal perikarya in the ARN and a decrease in rGH secretion, due to the GRF content deficiency (Terry et al., 1981 ; Millard et al., 1982) . These findings suggest a probable localization of GRF neuronal perikarya in the ARN. In this regard, it is of interest that the VMH situated close to the ARN did not respond to clonidine for rGH release, because the nucleus was an area for rGH release which was responsive to electrical stimulation within the hypothalamus. This implies that no noradrenergic mechanism is involved in the stimulation of rGH release induced by electrical stimulation.
Clonidine sensitive areas were observed in the PH and the MN in about one third of the cases (6/15). These areas are situated more posteriorly than the ARN. At present, we have no reasonable explanation of these clonidine-sensitive areas in the PN and the MN. On the other hand, recently we found an effect of a lesion located on the dorsal premammillary nucleus which abolished the increase in plasma rGH after electrical stimulation of the VMH (Kato et al., 1983) . It is not yet clear whether the premammillary nucleus plays a significant role but these findings may suggest a subtle function of the posterior hypothalamic nuclei in the regulation of rGH secretion.
Monoaminergic control of GRF neurons has not yet been established. Eden et al. (1981) claimed that GRF release is mediated by adrenergic mechanism. They observed a stimulatory effect of clonidine on rGH release in reserpin-pretreated rats even after the injection of antiserum to somatostatin. The inclease in plasma rGH by clonidine infusion, however, was rather slight in their experiments. The essential role of the adrenergic mechanism in the pulsatile secretion of rGH has been repeatedly confirmed by experiments with the use of inhibitors or a 
